Sonic Healthcare stock
Price history
−3.49% over the period1 year: from $20.89 (November 18, 2025) to $20.16 (November 18, 2026), −3.49%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 18, 2026 | $20.16 |
| October 30, 2026 | $19.57 |
| September 30, 2026 | $18.99 |
| August 31, 2026 | $19.59 |
| July 31, 2026 | $21.86 |
| June 30, 2026 | $20.81 |
| May 29, 2026 | $19.52 |
| April 30, 2026 | $19.77 |
| March 31, 2026 | $20.45 |
| February 27, 2026 | $23.83 |
| January 30, 2026 | $22.95 |
| December 31, 2025 | $22.61 |
| November 28, 2025 | $23.33 |
| November 18, 2025 | $20.89 |
At a glance
The company
Provider of laboratory medicine, radiology, and primary care medical services across Australia, the United States, Germany, and internationally
Latest results
Quarter to June 30, 2026 · EPS $0.70 (estimate $1.41)
TickerLandia's take on Sonic Healthcare
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 16 vs a median of 23 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 16 vs 31 (−48%) in a group of 11.
- Strong point: Dividend (89/100 in its group). Weak point: Profitability (21/100).
- “Value traps” (Australia): No. 1 of 3.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−16.93% from the 52-week high
Analysts · 16 analysts
Average target$22.12+9.71% vs. price
Buy 3 · Hold 10 · Sell 3 · Hold
TickerLandia Fingerprint: Sonic Healthcare
Compared with similar companies: very low price and very high dividend.
Financials and price compared with 27 companies in the diagnostics & research industry, worldwide. Momentum and risk compared with 1,069 Asia-Pacific stocks.
Pricevery low9
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 16.3 19 EV/EBITDA 8.50 6 Price/book 1.11 6 Price/sales 0.85 6 P/E (trailing 12 months) 16.2 10 Profitabilitylow21
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 33.0% 20 Net margin 5.6% 28 ROE 7.5% 25 ROA 3.9% 20 Operating margin 9.3% 13 Earnings stabilityaverage46
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 5.9% 31 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 61 Growthhigh62
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +9.98% 76 Revenue growth (year over year) +8.95% 54 Earnings growth (year over year) +21.55% 56 Financial strengthlow26
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength 3.86 14 Interest coverage 4.98 33 Debt/equitycounts in reverse: lower means more financial strength 0.69 43 Current ratio 0.99 13 Dividendvery high89
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratio 87.8% 91 Consecutive dividend years 33 years 85 Dividend yield 5.4% 90 Market momentumaverage45
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) −10.58% 26 Relative strength (6 months) +4.96% 57 1-year return −3.49% 39 Distance from 200-day average −0.84% 59 Risklow23
How much the price swings.
Metric Value Position in group Volatility (60 days) 20.0% 7 Maximum drawdown (12 months) 23.0% 23 Beta (1 year) 0.59 40
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 18, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Sonic Healthcare is cheaper than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2026), Sonic Healthcare's P/E today is 16.4, below the median of its last 10 fiscal years (23.0; between 10.9 and 27.5 from 2017 to 2026). Sonic Healthcare's P/E (trailing 12 months): 16.2, −48% against the median of a group of 11 similar companies (31.0).
Compared with 11 similar companies
| Metric | Sonic Healthcare | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 16.2 | Low | |
| Forward P/E | 16.3 | Low | |
| Operating margin | 9.3% | Low | |
| ROE | 7.5% | Middle | |
| Debt/equity | 0.69 | High |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Sonic Healthcare. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
$5.42B
Latest quarter · Q2 2026
Net income
$345.81M
Latest quarter · Q2 2026
Quarterly net margin
6.4%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $9.82B
- P/E
- 16.2
- EPS
- $1.23
- Volume
- 1.28M
- Daily trading
- €17.46M
- Dividend yield
- 5.36%
- Last ex-dividend on September 2, 2026
How Sonic Healthcare is changing
All resultsRevenue grew 4.4% a year on average over the last 5 years
Operating margin fell from 12.5% to 9.3%
Profits turn into cash: free cash flow equal to 143% of net income
Returns
Sonic Healthcare returns with dividends
$1,000 invested in Sonic Healthcare 5 years ago, on November 18, 2021, would be worth $617 today with dividends reinvested: −38.27% in total, −9.20% per year. On price alone it would be $507 (−49.28%).
| Period | Sonic Healthcare | S&P/ASX 200 | $1,000 becomes |
|---|---|---|---|
| 1 month | +8.80% | +0.42% | $1,088 |
| 6 months | +9.62% | +4.44% | $1,096 |
| Year to date | −10.84% | +1.94% | $892 |
| 1 year | +1.70% | +4.89% | $1,017 |
| 3 years | −20.92% | +25.85% | $791 |
| 5 years | −38.27% | +20.38% | $617 |
| 10 years | +28.76% | +65.75% | $1,288 |
Over the last 6 months it has done better than 31% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. S&P/ASX 200: price only. Calculate your investment
The chart in detail
Sonic Healthcare: technical analysis
Sonic Healthcare shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 56.8% below its highest close since January 1, 1990 ($46.71, December 30, 2021).
- Trend
- No clear trend
- RSI (14 sessions)
- 66
- Between 30 and 70
- vs 200-session average
- −0.84%
Support and resistance
Price areas where Sonic Healthcare has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$21.86+8.43%2 touches, last on July 8, 2026
- Resistance$20.90+3.67%2 touches, last on April 20, 2026
- Resistance$20.67+2.52%4 touches, last on July 24, 2026
- Last price$20.16
- Support$19.67−2.44%4 touches, last on September 17, 2026
- Support$18.88−6.35%2 touches, last on September 11, 2026
- Support$18.42−8.65%3 touches, last on October 2, 2026
Volatility and risk
Over the last year it has moved less than the S&P/ASX 200.
- Beta (1 year) vs S&P/ASX 200
- 0.59
- Volatility (60 sessions, annualised)
- 20.0%
- Largest fall in the last year
- −23.01%
In session, November 18, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Sonic Healthcare: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for Sonic Healthcare has been August: +5.13% on average, positive in 21 years out of 37. The weakest has been September: −0.47% on average, positive in 15 years out of 37. November, the current month, has been positive in 27 years out of 36 (+4.29% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.51% | +1.39% | 20 of 36 |
| February | +0.36% | 0.00% | 18 of 37 |
| March | +1.40% | 0.00% | 17 of 37 |
| April | +1.30% | +0.72% | 19 of 37 |
| May | +1.72% | +0.06% | 19 of 37 |
| June | +2.98% | +4.10% | 31 of 37 |
| July | +1.09% | 0.00% | 17 of 37 |
| August | +5.13% | +0.07% | 21 of 37 |
| September | −0.47% | −1.50% | 15 of 37 |
| October | −0.18% | −0.23% | 17 of 37 |
| November | +4.29% | +3.13% | 27 of 36 |
| December | +2.11% | −0.06% | 16 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Sonic Healthcare and its competitors
With revenue of AUD 10.9 billion in the fiscal year ended June 2026, the group runs laboratory and imaging services, with pathology testing ranging from haematology and genetics to toxicology and prenatal testing. Its radiology operations cover MRI, CT, ultrasound, mammography and PET CT, while its primary care activities include general practice clinics, occupational health services and skin cancer clinics. The group also offers clinical trial services and chronic disease management programmes, with operations in Australia, the United States and Germany as well as other international markets.
- Headquarters
- Sydney, Australia
- Employees
- 47,000
- Founded
- 1934
- Chief executive
- James Newcombe
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Sonic HealthcareSHL | $6.61B | 9.3% | 16.2 | +9.62% |
| WuXi XDC Cayman2268 | $10.89B | 28.1% | 52.7 | +21.16% |
| WuXi AppTec603259 | $66.5B | 44.8% | 16.1 | +38.20% |
| DiaSorinDIA | $4.56B | 22.3% | 31.0 | +16.24% |
| QiagenQIA | $10.3B | 26.7% | 27.3 | +58.79% |
| bioMérieuxBIM | $11.7B | 16.0% | 23.2 | +26.52% |
Same industry or related industries, similar size. Compare Sonic Healthcare with its competitors · Full profile
